There is a newer version of the record available.

Published October 26, 2023 | Version v1
Dataset Open

NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

  • 1. ROR icon Instituto Murciano de Investigación Biosanitaria
  • 2. Hematology and Medical Oncology Department, Hospital Universitario Morales-Meseguer, Centro Regional de Hemodonación, Murcia, Spain
  • 3. CIBERER CB15/00055 (U765)
  • 4. ROR icon Universidad Católica San Antonio de Murcia
  • 5. Universidad de Murcia

Files

Files (51.3 kB)

Name Size Download all
md5:6487a032b90c442b126270013d1c5382
51.3 kB Download